Annual Accounts Payable
$1.38 M
-$2.20 M-61.51%
01 July 2024
Summary:
Enzo Biochem annual accounts payable is currently $1.38 million, with the most recent change of -$2.20 million (-61.51%) on 01 July 2024. During the last 3 years, it has fallen by -$6.75 million (-83.06%). ENZ annual accounts payable is now -86.71% below its all-time high of $10.35 million, reached on 31 July 2017.ENZ Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.38 M
-$144.00 K-9.47%
01 July 2024
Summary:
Enzo Biochem quarterly accounts payable is currently $1.38 million, with the most recent change of -$144.00 thousand (-9.47%) on 01 July 2024. Over the past year, it has dropped by -$586.00 thousand (-29.87%). ENZ quarterly accounts payable is now -89.92% below its all-time high of $13.64 million, reached on 30 April 2023.ENZ Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENZ Accounts Payable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -61.5% | -29.9% |
3 y3 years | -83.1% | -76.8% |
5 y5 years | -81.0% | -84.1% |
ENZ Accounts Payable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -83.1% | at low | -89.9% | +4.4% |
5 y | 5 years | -83.8% | at low | -89.9% | +4.4% |
alltime | all time | -86.7% | +129.3% | -89.9% | +129.3% |
Enzo Biochem Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
July 2024 | $1.38 M(-61.5%) | $1.38 M(-9.5%) |
Apr 2024 | - | $1.52 M(+15.3%) |
Jan 2024 | - | $1.32 M(-32.8%) |
Oct 2023 | - | $1.96 M(-45.1%) |
July 2023 | $3.58 M(-3.8%) | $3.58 M(-73.8%) |
Apr 2023 | - | $13.64 M(+3.5%) |
Jan 2023 | - | $13.19 M(+62.6%) |
Oct 2022 | - | $8.11 M(+118.3%) |
July 2022 | $3.71 M(-54.3%) | $3.71 M(-51.5%) |
Apr 2022 | - | $7.66 M(+11.7%) |
Jan 2022 | - | $6.86 M(+15.7%) |
Oct 2021 | - | $5.93 M(-27.0%) |
July 2021 | $8.12 M(-4.5%) | $8.12 M(+35.1%) |
Apr 2021 | - | $6.01 M(+35.7%) |
Jan 2021 | - | $4.43 M(-43.5%) |
Oct 2020 | - | $7.84 M(-7.8%) |
July 2020 | $8.50 M(+17.2%) | $8.50 M(-0.2%) |
Apr 2020 | - | $8.52 M(+4.1%) |
Jan 2020 | - | $8.19 M(-5.2%) |
Oct 2019 | - | $8.63 M(+18.9%) |
July 2019 | $7.26 M(-23.7%) | $7.26 M(+13.0%) |
Apr 2019 | - | $6.42 M(-17.4%) |
Jan 2019 | - | $7.77 M(+8.6%) |
Oct 2018 | - | $7.16 M(-24.8%) |
July 2018 | $9.52 M(-8.1%) | $9.52 M(+15.3%) |
Apr 2018 | - | $8.25 M(-13.7%) |
Jan 2018 | - | $9.56 M(+0.1%) |
Oct 2017 | - | $9.56 M(-7.7%) |
July 2017 | $10.35 M(+5.0%) | $10.35 M(+10.1%) |
Apr 2017 | - | $9.40 M(-8.6%) |
Jan 2017 | - | $10.29 M(+10.1%) |
Oct 2016 | - | $9.34 M(-5.3%) |
July 2016 | $9.86 M(+12.5%) | $9.86 M(+7.7%) |
Apr 2016 | - | $9.15 M(-3.2%) |
Jan 2016 | - | $9.46 M(+0.1%) |
Oct 2015 | - | $9.45 M(+7.9%) |
July 2015 | $8.76 M(+6.3%) | $8.76 M(+15.1%) |
Apr 2015 | - | $7.61 M(+11.3%) |
Jan 2015 | - | $6.84 M(-3.6%) |
Oct 2014 | - | $7.10 M(-13.9%) |
July 2014 | $8.24 M(-2.8%) | $8.24 M(+11.3%) |
Apr 2014 | - | $7.41 M(-16.0%) |
Jan 2014 | - | $8.82 M(+1.1%) |
Oct 2013 | - | $8.72 M(+2.8%) |
July 2013 | $8.48 M(-6.0%) | $8.48 M(-7.7%) |
Apr 2013 | - | $9.19 M(+2.5%) |
Jan 2013 | - | $8.96 M(+13.9%) |
Oct 2012 | - | $7.87 M(-12.7%) |
July 2012 | $9.02 M(+14.8%) | $9.02 M(+25.2%) |
Apr 2012 | - | $7.20 M(-7.9%) |
Jan 2012 | - | $7.82 M(+19.8%) |
Oct 2011 | - | $6.53 M(-17.0%) |
July 2011 | $7.86 M(+21.7%) | $7.86 M(+9.9%) |
Apr 2011 | - | $7.15 M(-0.1%) |
Jan 2011 | - | $7.15 M(-1.0%) |
Oct 2010 | - | $7.23 M(+12.0%) |
July 2010 | $6.46 M(+52.2%) | $6.46 M(+42.5%) |
Apr 2010 | - | $4.53 M(-6.2%) |
Jan 2010 | - | $4.83 M(+17.9%) |
Oct 2009 | - | $4.10 M(-3.4%) |
July 2009 | $4.24 M(-1.3%) | $4.24 M(+43.7%) |
Apr 2009 | - | $2.95 M(-19.2%) |
Jan 2009 | - | $3.65 M(+9.2%) |
Oct 2008 | - | $3.34 M(-22.2%) |
July 2008 | $4.30 M(+4.6%) | $4.30 M(+23.3%) |
Apr 2008 | - | $3.49 M(-7.9%) |
Jan 2008 | - | $3.79 M(+1.0%) |
Oct 2007 | - | $3.75 M(-8.9%) |
July 2007 | $4.11 M | $4.11 M(+157.7%) |
Apr 2007 | - | $1.59 M(+61.9%) |
Date | Annual | Quarterly |
---|---|---|
Jan 2007 | - | $985.00 K(-29.2%) |
Oct 2006 | - | $1.39 M(+6.7%) |
July 2006 | $1.30 M(-46.0%) | $1.30 M(-8.3%) |
Apr 2006 | - | $1.42 M(-16.8%) |
Jan 2006 | - | $1.71 M(-6.7%) |
Oct 2005 | - | $1.83 M(-24.1%) |
July 2005 | $2.41 M(+15.4%) | $2.41 M(+99.7%) |
Apr 2005 | - | $1.21 M(+23.7%) |
Jan 2005 | - | $977.00 K(-18.2%) |
Oct 2004 | - | $1.20 M(-42.9%) |
July 2004 | $2.09 M(+58.4%) | $2.09 M(+67.4%) |
Apr 2004 | - | $1.25 M(-3.6%) |
Jan 2004 | - | $1.30 M(-38.1%) |
Oct 2003 | - | $2.10 M(+58.7%) |
July 2003 | $1.32 M(-12.6%) | $1.32 M(+119.4%) |
Apr 2003 | - | $602.00 K(-27.1%) |
Jan 2003 | - | $826.00 K(-26.1%) |
Oct 2002 | - | $1.12 M(-26.1%) |
July 2002 | $1.51 M(-25.8%) | $1.51 M(+71.9%) |
Apr 2002 | - | $880.00 K(-42.1%) |
Jan 2002 | - | $1.52 M(+47.0%) |
Oct 2001 | - | $1.03 M(-49.3%) |
July 2001 | $2.04 M(+38.7%) | $2.04 M(+52.7%) |
Apr 2001 | - | $1.34 M(-1.7%) |
Jan 2001 | - | $1.36 M(+53.7%) |
Oct 2000 | - | $884.00 K(-39.9%) |
July 2000 | $1.47 M(+22.5%) | $1.47 M(+29.1%) |
Apr 2000 | - | $1.14 M(+3.5%) |
Jan 2000 | - | $1.10 M(-38.9%) |
Oct 1999 | - | $1.80 M(+50.0%) |
July 1999 | $1.20 M(-14.3%) | $1.20 M(+20.0%) |
Apr 1999 | - | $1.00 M(-16.7%) |
Jan 1999 | - | $1.20 M(-25.0%) |
Oct 1998 | - | $1.60 M(+14.3%) |
July 1998 | $1.40 M(+27.3%) | $1.40 M(+7.7%) |
Apr 1998 | - | $1.30 M(-13.3%) |
Jan 1998 | - | $1.50 M(+87.5%) |
Oct 1997 | - | $800.00 K(-27.3%) |
July 1997 | $1.10 M(-15.4%) | $1.10 M(+22.2%) |
Apr 1997 | - | $900.00 K(0.0%) |
Jan 1997 | - | $900.00 K(-10.0%) |
Oct 1996 | - | $1.00 M(-23.1%) |
July 1996 | $1.30 M(-51.9%) | $1.30 M(+8.3%) |
Apr 1996 | - | $1.20 M(-14.3%) |
Jan 1996 | - | $1.40 M(+40.0%) |
Oct 1995 | - | $1.00 M(-63.0%) |
July 1995 | $2.70 M(-38.6%) | $2.70 M(-6.9%) |
Apr 1995 | - | $2.90 M(+31.8%) |
Jan 1995 | - | $2.20 M(-12.0%) |
Oct 1994 | - | $2.50 M(-43.2%) |
July 1994 | $4.40 M(+300.0%) | $4.40 M(+388.9%) |
Apr 1994 | - | $900.00 K(+12.5%) |
Jan 1994 | - | $800.00 K(0.0%) |
Oct 1993 | - | $800.00 K(-27.3%) |
July 1993 | $1.10 M(-56.0%) | $1.10 M(-57.7%) |
Apr 1993 | - | $2.60 M(+13.0%) |
Jan 1993 | - | $2.30 M(-8.0%) |
Oct 1992 | - | $2.50 M(0.0%) |
July 1992 | $2.50 M(0.0%) | $2.50 M(+8.7%) |
Apr 1992 | - | $2.30 M(-8.0%) |
Jan 1992 | - | $2.50 M(+4.2%) |
Oct 1991 | - | $2.40 M(-4.0%) |
July 1991 | $2.50 M(+212.5%) | $2.50 M(-10.7%) |
Apr 1991 | - | $2.80 M(+154.5%) |
Jan 1991 | - | $1.10 M(+37.5%) |
Oct 1990 | - | $800.00 K(0.0%) |
July 1990 | $800.00 K(+33.3%) | $800.00 K(0.0%) |
Apr 1990 | - | $800.00 K(+33.3%) |
Jan 1990 | - | $600.00 K(0.0%) |
Oct 1989 | - | $600.00 K(0.0%) |
July 1989 | $600.00 K | $600.00 K |
FAQ
- What is Enzo Biochem annual accounts payable?
- What is the all time high annual accounts payable for Enzo Biochem?
- What is Enzo Biochem annual accounts payable year-on-year change?
- What is Enzo Biochem quarterly accounts payable?
- What is the all time high quarterly accounts payable for Enzo Biochem?
- What is Enzo Biochem quarterly accounts payable year-on-year change?
What is Enzo Biochem annual accounts payable?
The current annual accounts payable of ENZ is $1.38 M
What is the all time high annual accounts payable for Enzo Biochem?
Enzo Biochem all-time high annual accounts payable is $10.35 M
What is Enzo Biochem annual accounts payable year-on-year change?
Over the past year, ENZ annual accounts payable has changed by -$2.20 M (-61.51%)
What is Enzo Biochem quarterly accounts payable?
The current quarterly accounts payable of ENZ is $1.38 M
What is the all time high quarterly accounts payable for Enzo Biochem?
Enzo Biochem all-time high quarterly accounts payable is $13.64 M
What is Enzo Biochem quarterly accounts payable year-on-year change?
Over the past year, ENZ quarterly accounts payable has changed by -$586.00 K (-29.87%)